Election 2014
SENSEX NIFTY
Moneycontrol.com India | Notes to Account > Pharmaceuticals > Notes to Account from Wockhardt Healthcare - BSE: 524286, NSE: RRMEDIPHAR
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > NOTES TO ACCOUNTS - Wockhardt Healthcare
Wockhardt Healthcare
BSE: 524286|NSE: RRMEDIPHAR|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
Wockhardt Healthcare is not traded in the last 30 days
Wockhardt Healthcare is not traded in the last 30 days
Notes to Accounts Year End : Dec '99
1. Secured Loans
 
 Non-Convertible Debentures Rs. 1000 lacs issued during October '98 to
 IDBI Bank Ltd. are secured against immoveable properties.
 
 2. Balance outstanding in Debtors, Creditors, Advances from Customers,
 Loans and Advances, Deposits and certain bank balances are subject to
 confirmation.
 
 3. Contingent Liability :
 
 Sales Tax Demand and Penalty disputed and pending in appeal
 
 Liability in respect of Bills Discounted with banks
 
 4. Previous period figures are regrouped wherever necessary to confirm
 with current period classification.  Previous period figures are not
 strictly comparable as the current accounting period is for Eighteen
 Months as against Fifteen months for the previous period.
 
 5. After obtaining necessary approvals from Shareholders and Board of
 directors, the company has filed a petition with Honourable High Court
 of Chennai, u/s. 391 and 394 of the Companies Act, 1956 for merger with
 Wockhardt Life Sciences Ltd.  The appointed date for merger is January
 2, 2000.  The Company is awaiting final Sanction of the Scheme of
 Merger from High Court, Chennai.
 
 6. Premium paid Rs. 334.67 lacs on redemption of debentures has been
 shown below the line in P&L account though as per accounting policy it
 is a charge for the period.
 
 7. No remuneration has been provided to Wholetime Director who has
 resigned on 27-08-98, since it was decided not to pay the same.
 
 8. Exchange difference arising out of the conversion at the period end
 rate charged to Profit and Loss Account is Rs. 2.15 lacs.
 
 9. Closing stock of Raw Materials, Finished Goods and Work-in-Progress
 do not include the element of Modvat Credit availed.
 
 10. The Company was considering the Interest paid on loan as Cost upto
 last accounting period while valuing the finished Goods and WIP.  For
 the current accounting period the interest paid has not been considered
 as Cost.  Because of this, the value of Finished Goods and WIP is lower
 by Rs. 8.46 lacs and Profit has been understated to that extent.
 
 11. The cumulative loss of Rs. 714.17 lacs exceeds Subscribed Capital
 and Reserves without considering the Share Application Money.
 
 12. Leave Salary has been accounted on cash basis upto last accounting
 period.  There has been a change in the accounting policy during the
 current accounting period by accounting the same on accrual basis.
 
 13. Amounts due to SSI Units is not determined as relevant information
 is not available.
Source : Dion Global Solutions Limited
Quick Links for wockhardthealthcare
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.